It correlates with distinct clinical (rash, alopecia, arthritis, Raynaud syndrome) and immunological (anti-Sm/SSA/SSB antibodies, decreased C3/C4, RF positivity) features. This evidence concerns the gene C4A and arthritic joint disease.